Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giovanni Palladini

Showing results (1-10 of 281) with videos related to

Pageof 29
Sort By:
Blood|April 8, 2016
What is new in diagnosis and management of light chain amyloidosis?Giovanni Palladini, Giampaolo Merlini
Blood|March 3, 2018
The elusive pathogenesis of Schnitzler syndromeGiovanni Palladini, Giampaolo Merlini
Blood|September 18, 2025
Dangerous clones with complex ties to AL amyloidosisGiovanni Palladini, Stefan Schönland
Haematologica|August 1, 2009
Current treatment of AL amyloidosisGiovanni Palladini, Giampaolo Merlini
Oncology (Williston Park, N.Y.)|September 6, 2011
Uniform risk-stratification and response criteria are paving the way to evidence-based treatment of AL amyloidosisGiovanni Palladini, Giampaolo Merlini
British Journal of Haematology|June 6, 2024
Response matters in light chain amyloidosis, whatever it takesGiovanni Palladini, Paolo Milani
Current Opinion in Oncology|December 24, 2010
Transplantation vs. conventional-dose therapy for amyloidosisGiovanni Palladini, Giampaolo Merlini
Blood|September 13, 2021
How I treat AL amyloidosisGiovanni Palladini, Giampaolo Merlini
Blood Advances|January 24, 2019
When should treatment of AL amyloidosis start at relapse? Early, to prevent organ progressionGiovanni Palladini, Giampaolo Merlini
Hematology. American Society of Hematology. Education Program|December 13, 2012
Differential diagnosis of monoclonal gammopathy of undetermined significanceGiampaolo Merlini, Giovanni Palladini
Pageof 29

Showing results (1-10 of 281) with videos related to

Sort By:
Pageof 29
Blood|April 8, 2016
What is new in diagnosis and management of light chain amyloidosis?Giovanni Palladini, Giampaolo Merlini
Blood|March 3, 2018
The elusive pathogenesis of Schnitzler syndromeGiovanni Palladini, Giampaolo Merlini
Blood|September 18, 2025
Dangerous clones with complex ties to AL amyloidosisGiovanni Palladini, Stefan Schönland
Haematologica|August 1, 2009
Current treatment of AL amyloidosisGiovanni Palladini, Giampaolo Merlini
Oncology (Williston Park, N.Y.)|September 6, 2011
Uniform risk-stratification and response criteria are paving the way to evidence-based treatment of AL amyloidosisGiovanni Palladini, Giampaolo Merlini
British Journal of Haematology|June 6, 2024
Response matters in light chain amyloidosis, whatever it takesGiovanni Palladini, Paolo Milani
Current Opinion in Oncology|December 24, 2010
Transplantation vs. conventional-dose therapy for amyloidosisGiovanni Palladini, Giampaolo Merlini
Blood|September 13, 2021
How I treat AL amyloidosisGiovanni Palladini, Giampaolo Merlini
Blood Advances|January 24, 2019
When should treatment of AL amyloidosis start at relapse? Early, to prevent organ progressionGiovanni Palladini, Giampaolo Merlini
Hematology. American Society of Hematology. Education Program|December 13, 2012
Differential diagnosis of monoclonal gammopathy of undetermined significanceGiampaolo Merlini, Giovanni Palladini
Pageof 29